Literature DB >> 16782733

Discordance between physician's and parent's global assessments in juvenile idiopathic arthritis.

F Sztajnbok1, D L Coronel-Martinez, A Diaz-Maldonado, C Novarini, A Pistorio, S Viola, N Ruperto, A Buoncompagni, A Martini, A Ravelli.   

Abstract

OBJECTIVE: To investigate the discrepancy between physician's and parent's global assessments of disease status and the factors explaining discordance in patients with juvenile idiopathic arthritis (JIA).
METHODS: The mothers of 197 patients with JIA rated the child's overall well-being on a 10 cm visual analogue scale (VAS) and the attending physician rated the child's overall disease activity on a 10 cm VAS. A discordance score was calculated by subtracting the physician's global assessment from that of the parent's, leading to the definition of three patient groups: (1) no discordance, when physician's and parent's assessments were within 1 cm of each other; (2) negative discordance, when parent's assessment was underrated relative to the physician; and (3) positive discordance, when parent's assessment was over-rated relative to the physician. Negative and positive discordance was defined as 'marked' when the difference between the two assessments was greater than 3 cm.
RESULTS: No discordance was found in 40.6% of the patients. Negative discordance was found in 51.3% of the patients, with 34% showing marked discordance. Positive discordance was found in 8.1% of the patients, with 2% showing marked discordance. Significant differences between groups included a shorter disease duration among patients with a markedly positive discordance (P = 0.02) and a greater frequency of ongoing second-line drug therapy among patients with no discordance or with positive discordance (P = 0.008). Patients with no discordance or with marked positive discordance had a significantly lower joint counts (P = 0.02-0.004).
CONCLUSION: Parents and physicians often perceive the health status of children with JIA differently, with parents providing most frequently lower rating.

Entities:  

Mesh:

Year:  2006        PMID: 16782733     DOI: 10.1093/rheumatology/kel201

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

1.  A randomized, double-blind, placebo-controlled trial of paracetamol and ketoprofren lysine salt for pain control in children with pharyngotonsillitis cared by family pediatricians.

Authors:  Nicolino Ruperto; Luigi Carozzino; Roberto Jamone; Federico Freschi; Gianfranco Picollo; Marcella Zera; Ornella Della Casa Alberighi; Enrica Salvatori; Alessandra Del Vecchio; Paolo Dionisio; Alberto Martini
Journal:  Ital J Pediatr       Date:  2011-09-29       Impact factor: 2.638

Review 2.  Network in pediatric rheumatology: the example of the Pediatric Rheumatology International Trials Organization.

Authors:  Nicolino Ruperto; Alberto Martini
Journal:  World J Pediatr       Date:  2008-08       Impact factor: 2.764

3.  Patient-Reported Outcomes Measurement Information System Tools for Collecting Patient-Reported Outcomes in Children With Juvenile Arthritis.

Authors:  Timothy G Brandon; Brandon D Becker; Katherine B Bevans; Pamela F Weiss
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-03       Impact factor: 4.794

4.  Health-related quality of life measures in genetic disorders: an outcome variable for consideration in clinical trials.

Authors:  David A Stevenson; John C Carey
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-08-15       Impact factor: 3.908

5.  Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis.

Authors:  Alysha J Taxter; E Paul Wileyto; Edward M Behrens; Pamela F Weiss
Journal:  J Rheumatol       Date:  2015-09-01       Impact factor: 4.666

Review 6.  Disease activity measures in paediatric rheumatic diseases.

Authors:  Nadia J Luca; Brian M Feldman
Journal:  Int J Rheumatol       Date:  2013-09-08

7.  Parent and Child Report of Pain and Fatigue in JIA: Does Disagreement between Parent and Child Predict Functional Outcomes?

Authors:  Amy C Gaultney; Maggie H Bromberg; Mark Connelly; Tracy Spears; Laura E Schanberg
Journal:  Children (Basel)       Date:  2017-01-30

8.  Self-management needs of Irish adolescents with Juvenile Idiopathic Arthritis (JIA): how can a Canadian web-based programme meet these needs?

Authors:  Grace O'Sullivan; Siobhán O'Higgins; Line Caes; Sophia Saetes; Brian E McGuire; Jennifer Stinson
Journal:  Pediatr Rheumatol Online J       Date:  2018-11-08       Impact factor: 3.054

9.  Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis.

Authors:  Elena Palmisani; Nicoletta Solari; Angela Pistorio; Nicolino Ruperto; Clara Malattia; Stefania Viola; Antonella Buoncompagni; Anna Loy; Alberto Martini; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2007-12-11       Impact factor: 3.054

10.  Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists.

Authors:  Wineke Armbrust; Jolanda G Kaak; Jelte Bouma; Otto T H M Lelieveld; Nico M Wulffraat; Pieter J J Sauer; Eric van Sonderen
Journal:  Pediatr Rheumatol Online J       Date:  2013-12-24       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.